Latest Publications

Share:

Client Alert: Access to Mifepristone Still Standing for Now, but Questions Remain

On Thursday morning, the Supreme Court issued its decision in FDA v. Alliance for Hippocratic Medicine. Justice Kavanaugh wrote for a unanimous Court dismissing the Alliance for Hippocratic Medicine from the case for lack of...more

Client Alert: What’s Next for Mifepristone?

Medication abortions using mifepristone and misoprostol now account for more than half of all abortions performed in the United States today. In the post-Dobbs era, medication abortion is critical to reproductive rights...more

Client Alert: New Year Brings New Guidance Related to Medication Abortion

The federal government started 2023 by clarifying important legal issues surrounding the use of medications for abortions. These changes come after much uncertainty—and controversy—around the availability of medication...more

Client Alert: Beyond the 2022 Midterm Election Headlines: Key Developments to Watch for in the Months to Come

On November 8, 2022, Americans headed to the polls for the United States’ 2022 midterm elections, with Democrats upsetting projections of a “Red Wave” and bucking historical trends to hew closely to the status quo. While the...more

Post-Dobbs Task Force - SCOTUS Overrules Roe v. Wade: Part IV: The Impact of Dobbs on Data Privacy – FTC v. Kochava

The Federal Trade Commission (FTC) recently filed a complaint against a data broker alleging that the collection and sale of precise location data significantly harms consumers, especially if the data contains information...more

SCOTUS Overrules Roe v. Wade: Part II: Outlining the Threat to Reproductive Rights Across the United States

On June 24, 2022, the Supreme Court issued its opinion in Dobbs v. Jackson Women's Health Organization. Authored by Justice Alito, the decision held that the Constitution does not grant a right to abortion (5-4), overturning...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide